2011 Fiscal Year Final Research Report
Basic and developmental research of a novel anti-tumor protein with dendritic cell-inducible activity.
Project/Area Number |
21390441
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Okayama University |
Principal Investigator |
NASU Yasutomo 岡山大学, 岡山大学病院, 教授 (20237572)
|
Co-Investigator(Kenkyū-buntansha) |
KUMON Hiromi 岡山大学, 大学院・医歯薬学総合研究科, 教授 (30144760)
KAKU Haruki 岡山大学, 岡山大学病院, 講師 (60346426)
|
Project Period (FY) |
2009 – 2011
|
Keywords | REIC/Dkk-3 / 前立腺癌 / 腎細胞癌 / 抗癌免疫 / 樹状細胞 |
Research Abstract |
The REIC/Dkk-3 gene has been reported to be a tumor suppressor and the expression is significantly downregulated in a broad range of cancer cell types. In this study, we focused the REIC protein and clarified the immunological anti-cancer function and the possible utility for the clinical use. We believe that current findings are available to create innovative cancer-targeting and immunological therapy for the cancer diseases including prostate cancer.
|
Research Products
(17 results)
-
-
-
-
-
[Journal Article] Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects.2011
Author(s)
Wang L, Kaku H, Huang P, Xu K, Yang K, Zhang J, Li M, Xie L, Wang X, Sakai A, Watanabe M, Nasu Y, Shimizu K, Kumon H, Na Y.
-
Journal Title
Acta Med Okayama
Volume: 65(5)
Pages: 315-23
Peer Reviewed
-
-
[Journal Article] Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.2011
Author(s)
Ochiai K, Watanabe M, Ueki H, Huang P, Fujii Y, Nasu Y, Noguchi H, Hirata T, Sakaguchi M, Huh NH, Kashiwakura Y, Kaku H, Kumon H
-
Journal Title
Biochem Biophys Res Commun
Volume: 412(2)
Pages: 391-5
Peer Reviewed
-
-
-
[Journal Article] Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.2011
Author(s)
Huang P, Chen J, Wang L, Na Y, Kaku H, Ueki H, Sasaki K, Yamaguchi K, Zhang K, Saika T, Nasu Y, Watanabe M, Kumon H
-
Journal Title
Peer Reviewed
-
[Journal Article] Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.2010
Author(s)
Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M, Ochiai K, Yamada H, Takei K, Ueki H, Huh NH, Li M, Kaku H, Na Y, Kumon H.
-
Journal Title
Int J Oncol
Volume: 37(6)
Pages: 1495-501
Peer Reviewed
-
-
[Journal Article] Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus(OBP-301) and IL-2 in a mouse model of renal cell carcinoma.2010
Author(s)
Huang P, Kaku H, Chen J, Kashiwakura Y, Saika T, Nasu Y, Urata Y, Fujiwara T, Watanabe M, Kumon H.
-
Journal Title
Cancer Gene Ther.
Volume: 17(7)
Pages: 484-91
Peer Reviewed
-
[Journal Article] A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate(EMP) versus standard dose EMP in patients with castration resistant prostate cancer.2010
Author(s)
Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Hirao Y, Moriya F, Suekane S, Matsuoka K, Komatsu N, Shichijo S, Yamada A, Itoh K.
-
Journal Title
Cancer Immunol Immunother.
Volume: 59(7)
Pages: 1001-9
Peer Reviewed
-
-
-